Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Feb;52(2):124–128. doi: 10.1136/jcp.52.2.124

Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.

R C Wong 1, R A Silvestrini 1, J A Savige 1, D A Fulcher 1, E M Benson 1
PMCID: PMC501056  PMID: 10396240

Abstract

BACKGROUND: The "classical" antineutrophil cytoplasmic antibody (C-ANCA) pattern seen on indirect immunofluorescence (IIF) is characterised by granular cytoplasmic staining showing central or interlobular accentuation, and is strongly associated with antiproteinase-3 antibodies (PR3-ANCA) and Wegener's granulomatosis. However, many laboratories report C-ANCA in the presence of any cytoplasmic IIF staining, regardless of pattern, which risks reducing the diagnostic value of this pattern. AIMS: To classify different cytoplasmic ANCA patterns and thus determine whether stringent application of the classical criteria for C-ANCA would produce better correlation between C-ANCA and (1) PR3-ANCA enzyme linked immunosorbent assay (ELISA) results; (2) a diagnosis of systemic vasculitis (including Wegener's granulomatosis). METHODS: 72 sera with cytoplasmic IIF collected over a two year period were analysed by IIF and a commercial PR3-ANCA ELISA kit. RESULTS: Three IIF patterns were defined: "classical/true" C-ANCA as described above (n = 27 (37.5%)); "flat" ANCA with homogeneous cytoplasmic staining (n = 21 (29%)); and "atypical" ANCA which included all other cytoplasmic patterns (n = 24 (33.5%)). Twenty five of the 27 true C-ANCA sera (92.5%) contained PR3-ANCA (p < 0.0001), but none of the 21 with flat ANCA and only one of the 24 with atypical ANCA. From clinical data on 23 of the 27 true C-ANCA positive patients, 20 (87%) had evidence of Wegener's granulomatosis or systemic vasculitis (p < 0.0001 v the other two patterns). However, none of 19 sera with flat ANCA and clinical data had evidence of systemic vasculitis. CONCLUSIONS: Restricting the term "c-ANCA" to the "classical" description of central/interlobular accentuation on IIF, will improve its correlation with PR3-ANCA positivity and a diagnosis of systemic vasculitis.

Full text

PDF
124

Images in this article

125Image
on p.125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitola P., Miettinen A., Mattila A., Matikainen M., Soppi E. Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. J Clin Pathol. 1995 Jul;48(7):645–647. doi: 10.1136/jcp.48.7.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baslund B., Segelmark M., Wiik A., Szpirt W., Petersen J., Wieslander J. Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice? Clin Exp Immunol. 1995 Mar;99(3):486–492. doi: 10.1111/j.1365-2249.1995.tb05577.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bini P., Gabay J. E., Teitel A., Melchior M., Zhou J. L., Elkon K. B. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. J Immunol. 1992 Aug 15;149(4):1409–1415. [PubMed] [Google Scholar]
  4. Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988 Jun 23;318(25):1651–1657. doi: 10.1056/NEJM198806233182504. [DOI] [PubMed] [Google Scholar]
  5. Goldschmeding R., van der Schoot C. E., ten Bokkel Huinink D., Hack C. E., van den Ende M. E., Kallenberg C. G., von dem Borne A. E. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest. 1989 Nov;84(5):1577–1587. doi: 10.1172/JCI114335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jennette J. C., Falk R. J., Andrassy K., Bacon P. A., Churg J., Gross W. L., Hagen E. C., Hoffman G. S., Hunder G. G., Kallenberg C. G. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994 Feb;37(2):187–192. doi: 10.1002/art.1780370206. [DOI] [PubMed] [Google Scholar]
  7. Jennings J. G., Chang L., Savige J. A. Anti-proteinase 3 antibodies, their characterization and disease associations. Clin Exp Immunol. 1994 Feb;95(2):251–256. doi: 10.1111/j.1365-2249.1994.tb06519.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lock R. J. ACP Broadsheet No 143: January 1994. Detection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol. 1994 Jan;47(1):4–8. doi: 10.1136/jcp.47.1.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nassberger L. Distribution of antineutrophil cytoplasmic autoantibodies in SLE patients with and without renal involvement. Am J Nephrol. 1996;16(6):548–549. doi: 10.1159/000169058. [DOI] [PubMed] [Google Scholar]
  10. Niles J. L. Antineutrophil cytoplasmic antibodies in the classification of vasculitis. Annu Rev Med. 1996;47:303–313. doi: 10.1146/annurev.med.47.1.303. [DOI] [PubMed] [Google Scholar]
  11. Papo M., Quer J. C., Pastor R. M., García-Pardo G., Prats E., Mirapeix E., Rodríguez R., Richart C. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. Am J Gastroenterol. 1996 Aug;91(8):1512–1515. [PubMed] [Google Scholar]
  12. Rao J. K., Allen N. B., Feussner J. R., Weinberger M. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet. 1995 Oct 7;346(8980):926–931. doi: 10.1016/s0140-6736(95)91555-9. [DOI] [PubMed] [Google Scholar]
  13. Rao J. K., Weinberger M., Oddone E. Z., Allen N. B., Landsman P., Feussner J. R. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med. 1995 Dec 15;123(12):925–932. doi: 10.7326/0003-4819-123-12-199512150-00005. [DOI] [PubMed] [Google Scholar]
  14. Rasmussen N., Wiik A. Indirect immunofluorescence examination for IgG-ANCA in sera submitted for the 1st international workshop on ANCA, 1988. APMIS Suppl. 1989;6:16–20. [PubMed] [Google Scholar]
  15. Roberts D. E. Antineutrophil cytoplasmic autoantibodies. Clin Lab Med. 1992 Mar;12(1):85–98. [PubMed] [Google Scholar]
  16. Savage C. O., Harper L., Adu D. Primary systemic vasculitis. Lancet. 1997 Feb 22;349(9051):553–558. doi: 10.1016/s0140-6736(97)80118-3. [DOI] [PubMed] [Google Scholar]
  17. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl. 1989;6:12–13. [PubMed] [Google Scholar]
  18. Zhao M. H., Jones S. J., Lockwood C. M. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol. 1995 Jan;99(1):49–56. doi: 10.1111/j.1365-2249.1995.tb03471.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES